홈MCP워크벤치Skills
홈워크벤치알림마이페이지
llms.txt · MCP 가이드개인정보처리방침 · 이용약관 · 지원v1.8.3
  1. 홈
  2. /반응

1-Methylpiperazine → 1-(4-Chloro-2-methoxyphenyl)-4-methylpiperazine

HRID 701
인쇄

반응식

HRID 701 반응식
CN1CCNCC1.COc1cc(Cl)ccc1I>CC(=O)O.CC(=O)O.CC(C)(C)[O-].Cc1ccccc1.[Na+].[Pd].c1ccc(P(c2ccccc2)c2ccc3ccccc3c2-c2c(P(c3ccccc3)c3ccccc3)ccc3ccccc23)cc1>COc1cc(Cl)ccc1N1CCN(C)CC1
참가 물질반응 조건실험 절차출처 및 근거반응 노트

참가 물질

7

반응물 2

HCID 531671-MethylpiperazineHCID 160792305-Chloro-2-iodoanisole

생성물 1

HCID 1190871951-(4-Chloro-2-methoxyphenyl)-4-methylpiperazine수율 0%

시약·촉매·용매 4

HCID 23676156Sodium t-butoxide시약HCID 634876Binap, (A+-)-촉매HCID 4144353Palladium (II) acetate촉매

반응 조건

온도
80 °C

실험 절차

1-methylpiperazine (0.021 mL, 0.19 mmol) was added to 4-chloro-1-iodo-2-methoxybenzene (50 mg, 0.19 mmol) and sodium 2-methylpropan-2-olate (35.8 mg, 0.37 mmol) in toluene (0.650 mL) and the solution degassed. rac-2,2'-Bis(diphenylphosphino)-1,1'-binaphthyl (11.60 mg, 0.02 mmol) and Palladium II acetate (4.18 mg, 0.02 mmol) were added to the resulting mixture and the vial stirred at 80 °C for 17 hours. LCMS revelead product peak, but not great. Product not isolated.

출처 및 근거

ORD 기록
ord-a9eb8bf838c248b3ad5908714b48274f
출처 데이터셋
750 AstraZeneca ELN dataset
원본 링크
출처 보기

반응 노트

이 페이지에서참가 물질반응 조건실험 절차출처 및 근거반응 노트
HCID 1140
Toluene
용매